KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Assets Growth (5y) (2017 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.94%
Dec 31, 2025 -2.31%
Sep 30, 2025 -2.20%
Jun 30, 2025 -1.71%
Mar 31, 2025 8.35%
Dec 31, 2024 8.69%
Sep 30, 2024 19.26%
Jun 30, 2024 19.96%
Mar 31, 2024 21.27%
Dec 31, 2023 17.81%
Sep 30, 2023 15.54%
Jun 30, 2023 17.04%
Mar 31, 2023 14.18%
Dec 31, 2022 14.42%
Sep 30, 2022 15.47%
Jun 30, 2022 16.41%
Mar 31, 2022 16.88%
Dec 31, 2021 17.26%
Sep 30, 2021 17.44%
Jun 30, 2021 17.10%
Mar 31, 2021 22.88%
Dec 31, 2020 23.20%
Sep 30, 2020 22.23%
Jun 30, 2020 22.66%
Mar 31, 2020 27.85%
Dec 31, 2019 26.50%
Sep 30, 2019 15.87%
Jun 30, 2019 14.49%
Mar 31, 2019 14.65%
Dec 31, 2018 15.24%
Sep 30, 2018 18.55%
Jun 30, 2018 17.17%
Mar 31, 2018 20.61%
Dec 31, 2017 21.25%